chr2-47414420-TAA-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2

The ENST00000233146.7(MSH2):​c.942+3_942+4delAA variant causes a splice region, intron change. The variant allele was found at a frequency of 0.179 in 965,430 control chromosomes in the GnomAD database, including 1,339 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.16 ( 371 hom., cov: 0)
Exomes 𝑓: 0.18 ( 1339 hom. )
Failed GnomAD Quality Control

Consequence

MSH2
ENST00000233146.7 splice_region, intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:11

Conservation

PhyloP100: 6.75

Publications

4 publications found
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6
Variant 2-47414420-TAA-T is Benign according to our data. Variant chr2-47414420-TAA-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 336427.
BS2
High Homozygotes in GnomAdExome4 at 1339 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000233146.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
NM_000251.3
MANE Select
c.942+28_942+29delAA
intron
N/ANP_000242.1P43246-1
MSH2
NM_001406674.1
c.942+28_942+29delAA
intron
N/ANP_001393603.1
MSH2
NM_001406631.1
c.942+28_942+29delAA
intron
N/ANP_001393560.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
ENST00000233146.7
TSL:1 MANE Select
c.942+3_942+4delAA
splice_region intron
N/AENSP00000233146.2P43246-1
MSH2
ENST00000406134.5
TSL:1
c.942+3_942+4delAA
splice_region intron
N/AENSP00000384199.1E9PHA6
MSH2
ENST00000918107.1
c.993+3_993+4delAA
splice_region intron
N/AENSP00000588166.1

Frequencies

GnomAD3 genomes
AF:
0.157
AC:
9816
AN:
62568
Hom.:
372
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.256
Gnomad AMR
AF:
0.163
Gnomad ASJ
AF:
0.192
Gnomad EAS
AF:
0.217
Gnomad SAS
AF:
0.252
Gnomad FIN
AF:
0.200
Gnomad MID
AF:
0.265
Gnomad NFE
AF:
0.142
Gnomad OTH
AF:
0.162
GnomAD2 exomes
AF:
0.0914
AC:
4790
AN:
52420
AF XY:
0.0872
show subpopulations
Gnomad AFR exome
AF:
0.0887
Gnomad AMR exome
AF:
0.119
Gnomad ASJ exome
AF:
0.0905
Gnomad EAS exome
AF:
0.116
Gnomad FIN exome
AF:
0.0335
Gnomad NFE exome
AF:
0.0841
Gnomad OTH exome
AF:
0.102
GnomAD4 exome
AF:
0.179
AC:
173109
AN:
965430
Hom.:
1339
AF XY:
0.176
AC XY:
84578
AN XY:
479320
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.149
AC:
3097
AN:
20816
American (AMR)
AF:
0.125
AC:
2250
AN:
18064
Ashkenazi Jewish (ASJ)
AF:
0.152
AC:
2206
AN:
14504
East Asian (EAS)
AF:
0.177
AC:
4047
AN:
22808
South Asian (SAS)
AF:
0.140
AC:
7857
AN:
56198
European-Finnish (FIN)
AF:
0.149
AC:
3102
AN:
20820
Middle Eastern (MID)
AF:
0.187
AC:
461
AN:
2460
European-Non Finnish (NFE)
AF:
0.186
AC:
143460
AN:
771958
Other (OTH)
AF:
0.175
AC:
6629
AN:
37802
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.398
Heterozygous variant carriers
0
7277
14554
21832
29109
36386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6196
12392
18588
24784
30980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.157
AC:
9812
AN:
62570
Hom.:
371
Cov.:
0
AF XY:
0.160
AC XY:
4436
AN XY:
27718
show subpopulations
African (AFR)
AF:
0.161
AC:
3117
AN:
19350
American (AMR)
AF:
0.163
AC:
682
AN:
4176
Ashkenazi Jewish (ASJ)
AF:
0.192
AC:
343
AN:
1782
East Asian (EAS)
AF:
0.215
AC:
357
AN:
1658
South Asian (SAS)
AF:
0.251
AC:
282
AN:
1122
European-Finnish (FIN)
AF:
0.200
AC:
127
AN:
636
Middle Eastern (MID)
AF:
0.270
AC:
27
AN:
100
European-Non Finnish (NFE)
AF:
0.142
AC:
4617
AN:
32436
Other (OTH)
AF:
0.160
AC:
125
AN:
782
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
417
834
1251
1668
2085
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
2
-
Lynch syndrome (2)
-
1
1
Lynch syndrome 1 (2)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)
-
-
1
MSH2-related disorder (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
6.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11309117; hg19: chr2-47641559; API